Contraceptive implants

Seminars in Reproductive Medicine

Volumn 28, Issue 2, 2010, Pages 110-117

  McDonald Mosley, Raegan ^a   Burke, Anne E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; Implanon; Implant; Norplant; Progestin only

Indexed keywords

ELCOMETRINE; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; NOMEGESTROL ACETATE;

FERTILITY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OBESITY; PREGNANCY; PUERPERIUM; REVIEW;

CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; DRUG MONITORING; FEMALE; HUMANS; LEVONORGESTREL; MENORRHAGIA; OBESITY; PELVIC PAIN;

EID: 77950544916     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1248135     Document Type: Review

References (52)

1. Gu S, Sivin I, Du M et al. Effectiveness of Norplant implants through seven years: a large-scale study in China. Contraception 1995 52 (2) 99-103
2. Meirik O, Farley T M., Sivin I. Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization. Obstet Gynecol 2001 97 (4) 539-547
3. Bongaarts J, Johansson E. Future trends in contraceptive prevalence and method mix in the developing world. Stud Fam Plann 2002 33 (1) 24-36
4. Croxatt H B. Progestin implants for female contraception. Contraception 2002 65 (1) 15-19
5. Zheng S R., Zheng H M., Qian S Z., Sang G W., Kaper R F. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. Eur J Contracept Reprod Health Care 1999 4 (2) 85-93
6. Darney P D. The androgenicity of progestins. Am J Med 1995 98 (1A, suppl 1A) 104S-110S
7. Bennink H J. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000 5 (suppl 2) 12-20
8. Ma G, Song C, Sun H, Yang J, Leng X. A biodegradable levonorgestrel- releasing implant made of PCL/F68 compound as tested in rats and dogs. Contraception 2006 74 (2) 141-147
9. Oettinger M, Barak S, Oettinger-Barak O, Ophira E. Subcutaneous implantation of pure crystalline estradiol pellets for conception control. Gynecol Obstet Invest 2005 59 (3) 119-125
10. Sivin I, Campodonico I, Kiriwat O et al. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. Hum Reprod 1998 13 (12) 3371-3378
11. Croxatto H B. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002 65 (1) 21-27
12. Diaz S, Pavez M, Miranda P, Robertson D N., Sivin I, Croxatto H B. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM). Contraception 1982 25 (5) 447-456
13. Sivin I, Lhteenmki P, Ranta S et al. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception 1997 55 (2) 81-85 (Pubitemid 27114530)
14. Brache V, Fandes A, Johansson E, Alvarez F. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. Contraception 1985 31 (3) 261-273
15. Dunson T R., Blumenthal P D., Alvarez F et al. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus. Fertil Steril 1998 69 (2) 258-266
16. Croxatto H D., Diaz S, Pavez M, Croxatto H B. Histopathology of the endometrium during continuous use of levonorgestrel In: Zatuchni GI, Goldsmith A, Shelton JD, Sciarra KK Long-Acting Contraceptive Delivery Systems. Philadelphia, PA Harper & Row 1983 290-295
17. Shaaban M M., Segal S, Salem H T., Ghaneimah S A., Khalifa E A., Ahmed A G. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Fertil Steril 1993 59 (5) 998-1002
18. Davies G C., Feng L X., Newton J R., Van Beek A, Coelingh-Bennink H J. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 1993 47 (3) 251-261
19. Croxatto H B., Mkrinen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 1998 58 (6, suppl) 91S-97S
20. Power J, French R, Cowan F. Subdermal implantable contraception versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy. Cochrane Database Syst Rev 2007 (3) CD001326
21. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005 71 (4) 306-308
22. Matiluko A A., Soundararjan L, Hogston P. Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz. J Fam Plann Reprod Health Care 2007 33 (4) 277-278
23. World Health Organization. Medical Eligibility Criteria for Contraceptive Use 2008 Update. Geneva, Switzerland World Health Organization 2008 WHO/RHR/09.19
24. Darney P, Patel A, Rosen K, Shapiro L S., Kaunitz A M. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009 91 (5) 1646-1653
25. Sivin I. Contraception with NORPLANT implants. Hum Reprod 1994 9 (10) 1818-1826
26. Huber J, Wenzl R. Pharmacokinetics of Implanon. An integrated analysis. Contraception 1998 58 (6, suppl) 85S-90S
27. Croxatto H B., Urbancsek J, Massai R, Coelingh Bennink H, van Beek A, Implanon Study Group. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Hum Reprod 1999 14 (4) 976-981
28. Zheng S R., Zheng H M., Qian S Z., Sang G W., Kaper R F. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception 1999 60 (1) 1-8
29. Funk S, Miller M M., Mishell D R. Jr et al, Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005 71 (5) 319-326
30. Cheng L, Zhu H, Wang A, Ren F, Chen J, Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000 15 (9) 1969-1972
31. Archer D F., Philput C B., Levine A S. et al. Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users. Contraception 2008 78 (2) 106-112
32. Weisberg E, Hickey M, Palmer D et al. A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Hum Reprod 2009 24 (8) 1852-1861
33. Buasang K, Taneepanichskul S. Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. J Med Assoc Thai 2009 92 (3) 301-307
34. Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996 174 (3) 919-922
35. Subakir S B., Setiadi E, Affandi B, Pringgoutomo S, Freisleben H J. Benefits of vitamin E supplementation to Norplant usersin vitro and in vivo studies. Toxicology 2000 148 (23) 173-178
36. Croxatto H B. Progestin implants. Steroids 2000 65 (1011) 681-685
37. Biswas A, Biswas S, Viegas O A. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function testsa randomized comparative study with Norplant implants. Contraception 2004 70 (5) 379-382
38. Nasr A, Nafeh H M. Effect of etonogestrel contraceptive implant (Implanon) on portal blood flow and liver functions. Contraception 2009 79 (3) 236-239
39. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 3rd ed. Geneva, Switzerland World Health Organization 2004
40. Biswas A, Viegas O A., Coeling Bennink H J., Korver T, Ratnam S S. Implanon contraceptive implants: effects on carbohydrate metabolism. Contraception 2001 63 (3) 137-141
41. Vicente L, Mendona D, Dingle M, Duarte R, Boavida J M. Etonogestrel implant in women with diabetes mellitus. Eur J Contracept Reprod Health Care 2008 13 (4) 387-395
42. Beerthuizen R, van Beek A, Massai R, Mkrinen L, Hout J, Bennink H C. Bone mineral density during long-term use of the progestogen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 2000 15 (1) 118-122
43. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device. Contraception 2000 62 (5) 239-246
44. Halderman L D., Nelson A L. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 2002 186 (6) 1250-1256 discussion 1256-1258
45. Walch K, Unfried G, Huber J et al. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosisa pilot study. Contraception 2009 79 (1) 29-34
46. Shokeir T, Amr M, Abdelshaheed M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet 2009 280 (3) 437-443
47. Shulman L P., Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception 2006 73 (4) 325-330
48. Mourtialon P, Tixier H, Loffroy R et al. Vascular complication after insertion of a subcutaneous contraceptive implant. Acta Obstet Gynecol Scand 2008 87 (11) 1256-1258
49. Levine J P., Sinofsky F E., Christ M F., Implanon US Study Group. Assessment of Implanon insertion and removal. Contraception 2008 78 (5) 409-417
50. Evans R, Holman R, Lindsay E. Migration of Implanon: two case reports. J Fam Plann Reprod Health Care 2005 31 (1) 71-72
51. National Institutes of Health. Clinical trials database. Available at: http://clinicaltrials.gov/ct2/show/NCT00847587?term=implanon&rank=5 Accessed August 29, 2009
52. Organon International. Implanon package insert. Oss, The Netherlands Organon July 2006